ArticleOncology letters2017

Survivin DEx3 as a biomarker of thyroid cancers: A study at the mRNA and protein level.

Joanna Waligórska-Stachura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.